Is the battle over 'skinny' generic labels headed to the Supreme Court?
The US appeals court for the federal circuit recently denied Teva Pharmaceuticals’ request to rehear a case on so-called “skinny” labels that sent shockwaves across …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
